Title : Rasagiline, an inhibitor of MAO-B, decreases colonic motility through elevating colonic dopamine content.

Pub. Date : 2018 Nov

PMID : 29956417






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Long-term administration of rasagiline can increase colonic DA thereby inhibiting colonic motility, suggesting that colonic MAO-B could be a potential drug target for colonic dysmotility. rasagiline monoamine oxidase B Homo sapiens